To ascertain the causal role of hyperglycaemia-induced ER stress in vivo, we employed a sodium–glucose co-transporter 2 inhibitor (SGLT2 inhibitor-dapagliflozin) to normalize blood glucose levels26 and the chemical chaperone TUDCA to attenuate ER stress27. This evidence concerns the gene SLC5A2 and Hyperglycemia.